Ask AI
ProCE Banner Activity

HIV Viral Blips: Interpretation and Clinical Management in the Era of Modern ART

Podcast

In this podcast, we examine the rise of viral “blips” in the era of highly sensitive HIV assays. As testing now detects viral loads down to 20 copies/mL, clinicians are increasingly faced with low-level detectable results that are often benign rather than signs of virologic failure. We discuss how to distinguish transient assay “noise” from persistent low-level viremia, review key guideline thresholds, and share practical strategies for follow-up and patient reassurance. Learn how clear, evidence-based communication can reduce unnecessary anxiety, avoid premature treatment changes, and support confidence in sustained viral suppression.

Released: July 14, 2026

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Define viral blips and differentiate them from persistent low-level viremia (LLV) and virologic failure (VF) using guideline-consistent thresholds

  • Interpret transient detectable HIV RNA results in the context of high-sensitivity assays (LOD ≤20 copies/mL) and modern ART regimens, including long-acting formulations

  • Identify when follow-up is warranted vs not warranted, focusing on the clinical context

  • Communicate the clinical significance of blips to patients to reduce "portal anxiety" while reinforcing U=U principles